Cambium Bio
A$0.41
0
-A$0.02-4.65% Tuesday 00:30
Statistics
Day High
0.41
Day Low
0.41
52W High
0.6
52W Low
0.19
Volume
2,915
Avg. Volume
11,597
Mkt Cap
9.42M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19FebExpected
Expected EPS
N/A
Actual EPS
-0.066156970075
Financials
-573.73%Profit Margin
Unprofitable1.34MRevenue
-7.69MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CMB.AU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Show more...
CEO
Dr. Edmund Kemp Waller FACP, M.D., Ph.D.
Country
AU
ISIN
AU0000327769
Listings
0 Comments
Share your thoughts
FAQ
What is Cambium Bio stock price today?▼
The current price of CMB.AU is A$0.41 AUD — it has decreased by -4.65% in the past 24 hours. Watch Cambium Bio stock price performance more closely on the chart.
What is Cambium Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cambium Bio stocks are traded under the ticker CMB.AU.
What is Cambium Bio market cap?▼
Today Cambium Bio has the market capitalization of 9.42M
When is the next Cambium Bio earnings date?▼
Cambium Bio is going to release the next earnings report on August 28, 2026.
What were Cambium Bio earnings last quarter?▼
CMB.AU earnings for the last quarter are -0.07 AUD per share, whereas the estimation was N/A AUD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A AUD per share.
What is Cambium Bio revenue for the last year?▼
Cambium Bio revenue for the last year amounts to 1.34M AUD.
What is Cambium Bio net income for the last year?▼
CMB.AU net income for the last year is -7.69M AUD.
In which sector is Cambium Bio located?▼
Cambium Bio operates in the Health Care sector.
When did Cambium Bio complete a stock split?▼
The last stock split for Cambium Bio was on July 04, 2024 with a ratio of 1:100.
Where is Cambium Bio headquartered?▼
Cambium Bio is headquartered in Bella Vista, AU.